Page 107 - Read Online
P. 107

Page 18 of 20                 Zhang et al. Cancer Drug Resist 2024;7:34  https://dx.doi.org/10.20517/cdr.2024.59

                    2020;19:48.  DOI  PubMed  PMC
               130.      Jiang W, Pan S, Chen X, Wang ZW, Zhu X. The role of lncRNAs and circRNAs in the PD-1/PD-L1 pathway in cancer
                    immunotherapy. Mol Cancer 2021;20:116.  DOI  PubMed  PMC
               131.      Zhou WY, Cai ZR, Liu J, Wang DS, Ju HQ, Xu RH. Circular RNA: metabolism, functions and interactions with proteins. Mol
                    Cancer 2020;19:172.  DOI  PubMed  PMC
               132.      Cheng J, Li G, Wang W, Stovall DB, Sui G, Li D. Circular RNAs with protein-coding ability in oncogenesis. Biochim Biophys Acta
                    Rev Cancer 2023;1878:188909.  DOI  PubMed
               133.      Zhang Q, Wang W, Zhou Q, et al. Roles of circRNAs in the tumour microenvironment. Mol Cancer 2020;19:14.  DOI  PubMed
                    PMC
               134.      Pisignano G, Michael DC, Visal TH, Pirlog R, Ladomery M, Calin GA. Going circular: history, present, and future of circRNAs in
                    cancer. Oncogene 2023;42:2783-800.  DOI  PubMed  PMC
               135.      Niu D, Wu Y, Lian J. Circular RNA vaccine in disease prevention and treatment. Signal Transduct Target Ther 2023;8:341.  DOI
                    PubMed  PMC
               136.      Wu S, Lu J, Zhu H, et al. A novel axis of circKIF4A-miR-637-STAT3 promotes brain metastasis in triple-negative breast cancer.
                    Cancer Lett 2024;581:216508.  DOI  PubMed
               137.      Wang Z, Yang L, Wu P, et al. The circROBO1/KLF5/FUS feedback loop regulates the liver metastasis of breast cancer by inhibiting
                    the selective autophagy of afadin. Mol Cancer 2022;21:29.  DOI  PubMed  PMC
               138.      Hong X, Li Q, Li J, et al. CircIPO7 promotes nasopharyngeal carcinoma metastasis and cisplatin chemoresistance by facilitating
                    YBX1 nuclear localization. Clin Cancer Res 2022;28:4521-35.  DOI  PubMed
               139.      Li Q, Zhao YH, Xu C, et al. Chemotherapy-induced senescence reprogramming promotes nasopharyngeal carcinoma metastasis by
                    circRNA-mediated PKR activation. Adv Sci 2023;10:e2205668.  DOI  PubMed  PMC
               140.      Debnath J, Gammoh N, Ryan KM. Autophagy and autophagy-related pathways in cancer. Nat Rev Mol Cell Biol 2023;24:560-75.
                    DOI  PubMed  PMC
               141.      Allen EA, Baehrecke EH. Autophagy in animal development. Cell Death Differ 2020;27:903-18.  DOI  PubMed  PMC
               142.      Gao W, Guo H, Niu M, et al. circPARD3 drives malignant progression and chemoresistance of laryngeal squamous cell carcinoma by
                    inhibiting autophagy through the PRKCI-Akt-mTOR pathway. Mol Cancer 2020;19:166.  DOI  PubMed  PMC
               143.      Liu F, Zhang J, Qin L, et al. Circular RNA EIF6 (Hsa_circ_0060060) sponges miR-144-3p to promote the cisplatin-resistance of
                    human thyroid carcinoma cells by autophagy regulation. Aging 2018;10:3806-20.  DOI  PubMed  PMC
               144.      Li X, He S, Ma B. Autophagy and autophagy-related proteins in cancer. Mol Cancer 2020;19:12.  DOI  PubMed  PMC
               145.      Ji X, Lv C, Huang J, Dong W, Sun W, Zhang H. ALKBH5-induced circular RNA NRIP1 promotes glycolysis in thyroid cancer cells
                    by targeting PKM2. Cancer Sci 2023;114:2318-34.  DOI  PubMed  PMC
                                      6
               146.      Cui Y, Liu J, Liu L, et al. m A-modified circFOXK2 targets GLUT1 to accelerate oral squamous cell carcinoma aerobic glycolysis.
                    Cancer Gene Ther 2023;30:163-71.  DOI  PubMed
                                                                                          6
               147.      Zhao W, Liu J, Wu J, et al. High-throughput microarray reveals the epitranscriptome-wide landscape of m A-modified circRNA in
                    oral squamous cell carcinoma. BMC Genomics 2022;23:611.  DOI  PubMed  PMC
               148.      Li J, Cao H, Yang J, Wang B. IGF2BP2-m6A-circMMP9 axis recruits ETS1 to promote TRIM59 transcription in laryngeal squamous
                    cell carcinoma. Sci Rep 2024;14:3014.  DOI  PubMed  PMC
               149.      Wu P, Fang X, Liu Y, et al. N6-methyladenosine modification of circCUX1 confers radioresistance of hypopharyngeal squamous cell
                    carcinoma through caspase1 pathway. Cell Death Dis 2021;12:298.  DOI  PubMed  PMC
               150.      Jiang X, Stockwell BR, Conrad M. Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol 2021;22:266-82.
                    DOI  PubMed  PMC
               151.      Sun S, Shen J, Jiang J, Wang F, Min J. Targeting ferroptosis opens new avenues for the development of novel therapeutics. Signal
                    Transduct Target Ther 2023;8:372.  DOI  PubMed  PMC
               152.      Zhu J, Wang X, Su Y, et al. Multifunctional nanolocks with GSH as the key for synergistic ferroptosis and anti-chemotherapeutic
                    resistance. Biomaterials 2022;288:121704.  DOI  PubMed
               153.      Zhang J, Ye ZW, Chakraborty P, et al. Microsomal glutathione transferase 1 controls metastasis and therapeutic response in
                    melanoma. Pharmacol Res 2023;196:106899.  DOI  PubMed  PMC
               154.      Yuan L, Li S, Chen Q, et al. EBV infection-induced GPX4 promotes chemoresistance and tumor progression in nasopharyngeal
                    carcinoma. Cell Death Differ 2022;29:1513-27.  DOI  PubMed  PMC
               155.      Roh JL, Kim EH, Jang H, Shin D. Nrf2 inhibition reverses the resistance of cisplatin-resistant head and neck cancer cells to
                    artesunate-induced ferroptosis. Redox Biol 2017;11:254-62.  DOI  PubMed  PMC
               156.      Shin D, Kim EH, Lee J, Roh JL. Nrf2 inhibition reverses resistance to GPX4 inhibitor-induced ferroptosis in head and neck cancer.
                    Free Radic Biol Med 2018;129:454-62.  DOI  PubMed
               157.      Lee J, You JH, Shin D, Roh JL. Inhibition of glutaredoxin 5 predisposes cisplatin-resistant head and neck cancer cells to ferroptosis.
                    Theranostics 2020;10:7775-86.  DOI  PubMed  PMC
               158.      Yang JY, Lei XY, He KY, et al. HMGA1 drives chemoresistance in esophageal squamous cell carcinoma by suppressing ferroptosis.
                    Cell Death Dis 2024;15:158.  DOI  PubMed  PMC
               159.      Angeli JP, Krysko DV, Conrad M. Ferroptosis at the crossroads of cancer-acquired drug resistance and immune evasion. Nat Rev
                    Cancer 2019;19:405-14.  DOI  PubMed
   102   103   104   105   106   107   108   109   110   111   112